Marleah
Marleah Dean Kruzel, PhD
Dr. Dean Kruzel is an Associate Professor at the University of South Florida, a Collaborator Member in the Health Outcomes & Behavior Program at the Moffitt Cancer Center, and a member of the Tampa General Cancer Institute. Her research interests are cancer communication and the communication of genetic risk information, and she is an expert on the health experiences and decisions of previvors. Dr. Dean Kruzel’s research has been published in numerous journals, such as Genetics in Medicine, Patient Education & Counseling, Health Communication, and Journal of Genetic Counseling. Her research has been funded by the National Cancer Institute, American Cancer Society, the Centers for Disease Control and Prevention, and the Patient-Centered Outcomes Research Institute.
The daughter of a 28-year-old breast cancer survivor and BRCA2-positive previvor herself, Dr. Dean Kruzel is committed to patient engagement and science communication. She participated in the CDC’s “Bring Your Brave” social media campaign designed to educate and inspire young women regarding breast cancer risk, and frequently gives community presentations to patients about research results. Dr. Dean Kruzel is also a member of the Scientific Advisory Board for FORCE (a leading nonprofit organization focused on hereditary cancers).
Marleah Dean Kruzel, PhD
- The University of South Florida
- Associate Professor
- TEDx Speaker
- Healthcare Communication Expert
Dr. Dean Kruzel is an Associate Professor at the University of South Florida, a Collaborator Member in the Health Outcomes & Behavior Program at the Moffitt Cancer Center, and a member of the Tampa General Cancer Institute. Her research interests are cancer communication and the communication of genetic risk information, and she is an expert on the health experiences and decisions of previvors. Dr. Dean Kruzel’s research has been published in numerous journals, such as Genetics in Medicine, Patient Education & Counseling, Health Communication, and Journal of Genetic Counseling. Her research has been funded by the National Cancer Institute, American Cancer Society, the Centers for Disease Control and Prevention, and the Patient-Centered Outcomes Research Institute.
The daughter of a 28-year-old breast cancer survivor and BRCA2-positive previvor herself, Dr. Dean Kruzel is committed to patient engagement and science communication. She participated in the CDC’s “Bring Your Brave” social media campaign designed to educate and inspire young women regarding breast cancer risk, and frequently gives community presentations to patients about research results. Dr. Dean Kruzel is also a member of the Scientific Advisory Board for FORCE (a leading nonprofit organization focused on hereditary cancers).